Our Work
Latham Advises Octopus Ventures on Automata’s US$50 Million Series B Financing
March 9, 2022
Transaction aims to accelerate the use of automation technology in the life sciences sector.
Latham & Watkins has advised Octopus Ventures on leading a US$50 million Series B funding round of Automata, an automation company helping life sciences rapidly innovate, diagnose, and discover at scale.
Alongside Octopus Ventures, returning investors Hummingbird, Latitude Ventures, ABB Technology Ventures, and Isomer Capital also participated in the investment round, as well as strategic investors such as In-Q-Tel, amongst others. The investment will be used to develop Automata Labs, the company’s lab automation platform, to support scientists working across diagnostics, drug discovery, and biotech in the UK and globally.
The Latham team was led by London corporate partner Shing Lo, with associate Samantha Peacock.